youtube_live
Q3 2026 earnings • released • EPS beat +71.06%
See resultschevron_right
ORY:BME
Oryzon Genomics SA
€2.35
arrow_downward
-8.93%(-0.23) 1D
Nov 13, 5:36:00 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORY...
Open
€2.60
High
€2.60
Low
€2.32
Mkt. cap
226.43M
Avg. vol.
223.59K
Volume
1.25M
52-wk high
€3.56
52-wk low
€2.29
EPS
-€0.05
Shares outstanding
84.33M
No. of employees
46
Open
€2.60
High
€2.60
Low
€2.32
Mkt. cap
226.43M
Avg. vol.
223.59K
Volume
1.25M
52-wk high
€3.56
52-wk low
€2.29
EPS
-€0.05
Shares outstanding
84.33M
No. of employees
46
News stories
From web sources and news partners
Barron's
·
25 minutes ago
Amundi Core S&P 500 UCITS ETF Overview (SNP5)
Traders Union
·
13 minutes ago
Gate.io announces indicative USDT subscriptions for Anthropic IPO ahead of Nasdaq listing
AP News
·
1 day ago
Microsoft outage shows the risks of relying on a single technology provider for essential services
Investor's Business Daily
·
4 hours ago
Futures Loom As Bitcoin Dives In Shaky Rally. What To Do Now.
About Oryzon Genomics SA
CEOCarlos Buesa
Employees46
Founded2000
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteoryzon.com